Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.
| CAGE Code | 7WTM8 |
|---|---|
| Company Operating Status | Active |
| Full Address | 225 2nd Ave, Waltham, MA 02451, US |
| Public/Private | Public |
| Wikidata ID | Q28155329 |